This inventor holds 2 USPTO granted patents. Top assignee: Behringwerke Aktiengesellschaft. Active years: 1993-1994.
Company Filing History:
Years Active: 1993-1994
Title: Eugen Amann: Innovator in Genetic Manipulation
Introduction
Eugen Amann is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of genetic manipulation, particularly in the development of proteins. With a total of 2 patents, his work has implications for biotechnology and medical research.
Latest Patents
Amann's latest patents focus on Protein PP15, which is prepared through genetic manipulation. Specific fragments of the protein PP15 were created by enzyme cleavage. Using statistical data, specific oligonucleotides were selected from those coding for the PP15 fragments. These oligonucleotides were then utilized as probes to successfully screen a cDNA bank of mature human placenta, leading to the isolation of the complete cDNA of PP15. The cDNA was sequenced and characterized, allowing for the preparation of PP15 protein in both prokaryotic and eukaryotic cells.
Career Highlights
Eugen Amann is associated with Behringwerke Aktiengesellschaft, where he has been instrumental in advancing research in protein development. His innovative approaches have paved the way for new methodologies in genetic engineering.
Collaborations
Amann has collaborated with notable colleagues such as Ulrich Grundmann and Karl-Josef Abel. Their combined expertise has contributed to the success of various projects in the field.
Conclusion
Eugen Amann's work in genetic manipulation and protein development exemplifies the impact of innovation in biotechnology. His patents and collaborations highlight the importance of research in advancing medical science.